These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36945751)

  • 21. Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides.
    Liu L; Lauro BM; Wolfe MS; Selkoe DJ
    J Biol Chem; 2021; 296():100393. PubMed ID: 33571524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
    Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
    Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review.
    Gehlot P; Kumar S; Kumar Vyas V; Singh Choudhary B; Sharma M; Malik R
    Bioorg Med Chem; 2022 Nov; 74():117047. PubMed ID: 36265268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of amyloid-beta-peptide generation by subcellular trafficking of the beta-amyloid precursor protein and beta-secretase.
    Walter J
    Neurodegener Dis; 2006; 3(4-5):247-54. PubMed ID: 17047364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Production and catabolism of amyloid peptides in Alzheimer's disease].
    Checler F
    Therapie; 2010; 65(5):409-14. PubMed ID: 21144475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are Abeta and its derivatives causative agents or innocent bystanders in AD?
    Robakis NK
    Neurodegener Dis; 2010; 7(1-3):32-7. PubMed ID: 20160455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
    Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
    Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative β-secretases.
    Armbrust F; Bickenbach K; Marengo L; Pietrzik C; Becker-Pauly C
    Biochim Biophys Acta Mol Cell Res; 2022 Mar; 1869(3):119164. PubMed ID: 34699873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of γ-secretase activity by multiple enzyme-substrate interactions: implications in pathogenesis of Alzheimer's disease.
    Svedružić ZM; Popović K; Smoljan I; Sendula-Jengić V
    PLoS One; 2012; 7(3):e32293. PubMed ID: 22479317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The amyloid precursor protein: a converging point in Alzheimer's disease.
    Delport A; Hewer R
    Mol Neurobiol; 2022 Jul; 59(7):4501-4516. PubMed ID: 35579846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid precursor protein processing and bioenergetics.
    Wilkins HM; Swerdlow RH
    Brain Res Bull; 2017 Jul; 133():71-79. PubMed ID: 27545490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
    Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
    Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Discovery to Drug Development of BACE1 Inhibitor as Antialzheimer's: A Review.
    Munj SM; Patil PB
    Curr Top Med Chem; 2023; 23(2):77-97. PubMed ID: 36579387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation Signaling in APP Processing in Alzheimer's Disease.
    Zhang T; Chen D; Lee TH
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer's Disease.
    Kabir ER; Chowdhury NM; Yasmin H; Kabir MT; Akter R; Perveen A; Ashraf GM; Akter S; Rahman MH; Sweilam SH
    Curr Neuropharmacol; 2023; 21(4):787-807. PubMed ID: 36221865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible role of glycation in the regulation of amyloid β precursor protein processing leading to amyloid β accumulation.
    Patil GV; Joshi RS; Kazi RS; Kulsange SE; Kulkarni MJ
    Med Hypotheses; 2020 Sep; 142():109799. PubMed ID: 32388478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer's Disease: A Review.
    Ahmad SS; Younis K; Philippe J; Aschner M; Khan H
    CNS Neurol Disord Drug Targets; 2022; 21(7):610-620. PubMed ID: 34382514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.